Key Market Indicators
By 2028, the Czech Republic's vaccination coverage for children aged one year is projected to reach 95%, down from 96% in 2023. This represents an average annual decline of 0.2 percentage points. The country's vaccination coverage has remained stable since 1998. In terms of vaccine imports, the Czech market is expected to grow. Imports are projected to reach approximately $135 million by 2028, up from $123 million in 2023. This reflects a compound annual growth rate (CAGR) of 1.4%. The demand for vaccines in the Czech Republic has seen a consistent annual increase of 3.4% since 1998. On the export front, the Czech Republic is anticipated to see a decline. Vaccine exports are forecasted to fall to around $14 million by 2028, down from $15 million in 2023, marking an average annual decrease of 1.3%. Despite this decline, Czech vaccine supply has grown by 1.5% per year since 1998. In 2023, the Czech Republic ranked 27th in vaccine exports, with Israel slightly ahead at $15 million. Belgium, the United Kingdom, and France secured the second, third, and fourth spots, respectively, in this ranking.
